China, Nov. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Retrospective analysis based on joint prediction of pCR and long-term prognosis in breast cancer patients receiving neoadjuvant therapy using multiple category indicators'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600136197
Registration Time: 2026/11/06
Type: Observational study
Primary Sponsor: Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=331026
Published by HT Digital Content Services with permission from Health Daily Digest....